Related Experiment Video
Updated: Oct 17, 2026

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
Published on: July 20, 2022
A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C
1Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Mitomycin C (MMC) is a prototype bioreductive drug employed to treat a variety of cancers including head and neck cancer. Among the various enzymes, dicoumarol inhibitable cytosolic NAD(P)H:quinone oxidoreductase1 (NQO1) was shown to catalyse bioreductive activation of MMC leading to cross-linking of the DNA and cytotoxicity. However, the role of NQO1 in metabolic activation of MMC has been disputed. In this report, we present cellular and animal models to demonstrate that NQO1 may play only a minor role in metabolic activation of MMC. We further demonstrate that bioreductive activation of MMC is catalysed by a unique cytosolic activity which is related but distinct from NQO1. Chinese hamster ovary (CHO) cells were developed that permanently express higher levels of cDNA-derived NQO1. These cells showed significantly increased protection against menadione toxicity. However, they failed to demonstrate higher cytotoxicity due to exposure to MMC under oxygen (normal air) or hypoxia, as compared to the wild-type control CHO cells. Disruption of the NQO1 gene by homologous recombination generated NQO1-/- mice that do not express the NQO1 gene resulting in the loss of NQO1 protein and activity. The cytosolic fractions from liver and colon tissues of NQO1-/- mice showed similar amounts of DNA cross-linking upon exposure to MMC, as observed in NQO1+/+ mice. The unique cytosolic activity that activated MMC in cytosolic fractions of liver and colon tissues of NQO1-/- mice was designated as cytosolic MMC reductase. This activity, like NQO1, was inhibited by dicoumarol and immunologically related to NQO1.
Insights
Dicoumarol inhibitable NAD(P)H:quinone oxidoreductase1 (NQO1) may play a minor role in Mitomycin C (MMC) activation. A distinct cytosolic activity, termed cytosolic MMC reductase, appears to be the primary catalyst for bioreductive activation of this anti-cancer drug.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Mitomycin C (MMC) is a bioreductive anticancer drug used for various cancers.
- NAD(P)H:quinone oxidoreductase1 (NQO1) has been implicated in the bioreductive activation of MMC, leading to DNA cross-linking and cytotoxicity.
- The precise role of NQO1 in MMC metabolic activation remains debated.
Purpose of the Study:
- To investigate the role of NQO1 in the bioreductive activation of Mitomycin C (MMC).
- To identify the specific enzyme(s) responsible for catalyzing MMC activation.
- To differentiate the activity of NQO1 from other potential MMC-activating enzymes.
Main Methods:
- Development of Chinese hamster ovary (CHO) cells with stably overexpressed NQO1.
- Generation of NQO1 knockout (NQO1-/-) mice using homologous recombination.
- Analysis of MMC-induced DNA cross-linking and cytotoxicity in NQO1-overexpressing cells and NQO1-/- mice.
- Characterization of cytosolic enzyme activity in liver and colon tissues.
Main Results:
- NQO1-overexpressing CHO cells showed increased protection against menadione but no altered sensitivity to MMC.
- NQO1-/- mice exhibited similar levels of MMC-induced DNA cross-linking in liver and colon cytosolic fractions compared to wild-type mice.
- A unique dicoumarol-inhibitable and immunologically related cytosolic activity, designated cytosolic MMC reductase, was identified as responsible for MMC activation in NQO1-deficient tissues.
Conclusions:
- NQO1 plays a minimal role in the bioreductive activation of Mitomycin C.
- A distinct cytosolic enzyme, cytosolic MMC reductase, is the primary catalyst for MMC activation.
- These findings clarify the metabolic activation pathway of MMC, potentially impacting its therapeutic application.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Bioactivation and Tissue Toxicity
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondria
Electron Transport Chain: Complex III and IV

